Caption Management’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,900
| Closed | -$252K | – | 1882 |
|
|
2022
Q3 | $252K | Buy |
+4,900
| New | +$203K | ﹤0.01% | 1211 |
|
|
2022
Q2 | – | Sell |
-129,789
| Closed | -$2.86M | – | 1984 |
|
|
2022
Q1 | $3.25M | Buy |
129,789
+102,589
| +377% | +$2.88M | 0.04% | 584 |
|
|
2021
Q4 | $990K | Sell |
27,200
-185,482
| -87% | -$6.51M | 0.01% | 1051 |
|
|
2021
Q3 | $3.64M | Buy |
+212,682
| New | +$3.31M | 0.04% | 563 |
|
|
2021
Q2 | – | Sell |
-11,600
| Closed | -$286K | – | 1670 |
|
|
2021
Q1 | $594K | Buy |
+11,600
| New | +$698K | 0.01% | 779 |
|
|
2020
Q4 | – | Sell |
-85,000
| Closed | -$4.66M | – | 1326 |
|
|
2020
Q3 | $4.66M | Sell |
85,000
-47,797
| -36% | -$2.57M | 0.11% | 227 |
|
|
2020
Q2 | $7.64M | Sell |
132,797
-60,703
| -31% | -$3.3M | 0.25% | 101 |
|
|
2020
Q1 | $7.78M | Buy |
193,500
+77,099
| +66% | +$3.27M | 0.44% | 42 |
|
|
2019
Q4 | $4.6M | Buy |
116,401
+51,401
| +79% | +$903K | 0.15% | 182 |
|
|
2019
Q3 | $440K | Buy |
65,000
+54,000
| +491% | +$405K | 0.02% | 501 |
|
|
2019
Q2 | $102K | Buy |
+11,000
| New | +$127K | 0.01% | 604 |
|
Other funds holding CCXI
Caption Management's CCXI Position: Q4 2022 in Review
Caption Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 4,900 shares — an estimated $252K sold.
Caption Management first reported a position in CCXI in Q2 2019 and held it in 11 quarters. The position peaked at $7.78M in Q1 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- Caption Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- Caption Management sold 4,900 ChemoCentryx, Inc. shares in Q4 2022, an estimated $252K.
- Caption Management first reported a position in ChemoCentryx, Inc. in Q2 2019 and held it in 11 quarters.
- Caption Management's ChemoCentryx, Inc. position peaked at $7.78M in Q1 2020.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on Caption Management's 13F filing for Q4 2022, filed 14 Feb 2023.